Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results at 8 a.m. ET on November 6, 2024
Teva Pharmaceutical Industries (NYSE and TASE: TEVA) has announced its plans to release its third quarter 2024 financial results on Wednesday, November 6, 2024, at 7:00 a.m. ET. Following this release, the company will host a conference call and live webcast at 8:00 a.m. ET on the same day.
Interested participants are required to register in advance to obtain a local or toll-free phone number and personal pin for the call. A live webcast will be available on Teva's investor relations website. After the call's conclusion, a replay of the webcast will be accessible within 24 hours on the company's website.
Teva Pharmaceutical Industries (NYSE e TASE: TEVA) ha annunciato i suoi piani per pubblicare i risultati finanziari del terzo trimestre 2024 mercoledì 6 novembre 2024, alle 7:00 a.m. ET. Dopo questo annuncio, l'azienda ospiterà una chiamata in conferenza e un webcast dal vivo alle 8:00 a.m. ET nello stesso giorno.
I partecipanti interessati devono registrarsi in anticipo per ottenere un numero di telefono locale o gratuito e un pin personale per la chiamata. Un webcast dal vivo sarà disponibile sul sito web delle relazioni con gli investitori di Teva. Dopo la conclusione della chiamata, una registrazione del webcast sarà accessibile entro 24 ore sul sito web dell'azienda.
Teva Pharmaceutical Industries (NYSE y TASE: TEVA) ha anunciado sus planes para publicar sus resultados financieros del tercer trimestre de 2024 el miércoles 6 de noviembre de 2024, a las 7:00 a.m. ET. Tras este anuncio, la empresa realizará una llamada de conferencia y un webcast en vivo a las 8:00 a.m. ET el mismo día.
Los participantes interesados deben registrarse con anticipación para obtener un número de teléfono local o gratuito y un pin personal para la llamada. Un webcast en vivo estará disponible en el sitio web de relaciones con los inversores de Teva. Después de que termine la llamada, se podrá acceder a una repetición del webcast dentro de las 24 horas en el sitio web de la empresa.
테바 제약 산업(TEV: NYSE 및 TASE)은 2024년 3분기 재무 결과를 2024년 11월 6일 수요일 오전 7시(ET)에 발표할 계획이라고 발표했습니다. 발표 후, 회사는 같은 날 오전 8시(ET)에 컨퍼런스 콜 및 라이브 웹캐스트를 주최합니다.
참여를 원하는 사람들은 사전 등록을 해야 하며, 전화 관련 번호와 개인 PIN을 받을 수 있습니다. 라이브 웹캐스트는 테바의 투자자 관계 웹사이트에서 볼 수 있습니다. 콜이 종료된 후, 웹캐스트의 재생은 회사의 웹사이트에서 24시간 이내에 접속할 수 있습니다.
Teva Pharmaceutical Industries (NYSE et TASE : TEVA) a annoncé ses plans pour publier ses résultats financiers du troisième trimestre 2024 le mercredi 6 novembre 2024, à 7h00 ET. Suite à cette publication, la société animera un appel conférence et un webcast en direct à 8h00 ET le même jour.
Les participants intéressés doivent s’inscrire à l’avance pour obtenir un numéro de téléphone local ou gratuit et un code PIN personnel pour l’appel. Un webcast en direct sera disponible sur le site internet des relations investisseurs de Teva. Après la fin de l’appel, un enregistrement du webcast sera accessible dans les 24 heures sur le site internet de la société.
Teva Pharmaceutical Industries (NYSE und TASE: TEVA) hat seine Pläne bekannt gegeben, die Finanzergebnisse für das dritte Quartal 2024 am Mittwoch, den 6. November 2024, um 7:00 Uhr ET zu veröffentlichen. Nach dieser Veröffentlichung wird das Unternehmen am selben Tag um 8:00 Uhr ET eine Konferenzschaltung und einen Live-Webcast veranstalten.
Interessierte Teilnehmer müssen sich im Voraus registrieren, um eine lokale oder gebührenfreie Telefonnummer und eine persönliche PIN für den Anruf zu erhalten. Ein Live-Webcast wird auf der Investor-Relations-Website von Teva verfügbar sein. Nach Abschluss des Anrufs ist eine Wiederholung des Webcasts innerhalb von 24 Stunden auf der Website des Unternehmens verfügbar.
- None.
- None.
TEL AVIV, Israel, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its financial results for the third quarter of 2024 on Wednesday, November 6, 2024, at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 8:00 a.m. ET.
In order to participate, please register in advance here to obtain a local or toll-free phone number and your personal pin.
A live webcast of the call will be available on Teva's website at: https://ir.tevapharm.com/Events-and-Presentations
Following the conclusion of the call, a replay of the webcast will be available within 24 hours on Teva's website.
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a global pharmaceutical leader with a category-defying portfolio, harnessing our generics expertise and stepping up innovation to continue the momentum behind the discovery, delivery, and expanded development of modern medicine. For over 120 years, Teva's commitment to bettering health has never wavered. Today, the company’s global network of capabilities enables its ~37,000 employees across 58 markets to push the boundaries of scientific innovation and deliver quality medicines to help improve health outcomes of millions of patients every day. To learn more about how Teva is all in for better health, visit www.tevapharm.com.
Cautionary Note Regarding Forward-Looking Statements
This press release and the conference call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to: our ability to successfully compete in the marketplace including our ability to successfully execute our Pivot to Growth strategy; our substantial indebtedness; our business and operations in general; compliance, regulatory and litigation matters; other financial and economic risks; and other factors discussed in this press release, in our Quarterly Report on Form 10-Q for the second quarter of 2024, and in our Annual Report on Form 10-K for the year ended December 31, 2023, including in the sections captioned "Risk Factors." Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.
| IR Contacts | Ran Meir | +1 (267) 468-4475 | |
| Yael Ashman | +972 (3) 914 8262 | ||
| Sanjeev Sharma | +1 (973) 658 2700 | ||
| Media Contacts | Kelley Dougherty Eden Klein | +1 (973) 832-2810 +972 (3) 906 2645 |
FAQ
When will Teva Pharmaceutical (TEVA) release its Q3 2024 financial results?
What time is Teva's (TEVA) Q3 2024 earnings conference call scheduled for?
How can investors participate in Teva's (TEVA) Q3 2024 earnings call?
Where can I find the replay of Teva's (TEVA) Q3 2024 earnings call?
